Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 8.8217.227.287.747.99

What is the latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 8.82 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20258.82
Mar202417.22
Mar20237.28
Mar20227.74
Mar20217.99

How is Working Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2025 8.82
-48.78
Mar2024 17.22
136.54
Mar2023 7.28
-5.94
Mar2022 7.74
-3.13
Mar2021 7.99 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,830.0 Cr 5.3% 7% 28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,160.0 Cr 1.7% 7.3% 0% Stock Analytics
DIVIS LABORATORIES ₹172,288.0 Cr 1.8% 0.9% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,440.0 Cr 1.3% 4.4% 14.9% Stock Analytics
CIPLA ₹123,149.0 Cr 0.9% -2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,369.0 Cr 0.5% -3.1% 3.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5.3%

7%

28.7%

SENSEX

0.1%

1.1%

8.4%


You may also like the below Video Courses